- Provide support to all UNC intellectual property-based startups, with a primary focus on: o Gene therapies, RNA, small molecule, peptides, and antibodies for oncology, immunomodulation, and rare diseases o Medical devices, research tools, and diagnostics- Key decision maker on whether or not to spin-out a company from university research and license negotiations- Advice startup companies through investor meetings, funding pitches, and negotiation strategies- Led alliance between UNC and Duke to implement a $1M project; negotiated ongoing partnership and brought in additional partners.- Serve as the Lead Alliance for UNC with 12 other institutions from the Mid-Atlantic region to implement a 5-year program- Negotiate discounted pricing with Contract Research Organizations for startup support contracts- Forge new relationships with health systems, payers, and innovators to align pathways for collaboration - Work closely with UNC’s Health System/Medical school to evaluate clinicians’ inventions and translational studies- Train and support faculty and clinicians in the creation of product development and regulatory strategy plans-Raise awareness of department’s services to stakeholders by creating a marketing and communications strategy- Manage 7500 SF wet-lab incubator for intellectual-property based startups- Experience using salesforce for data capture and business lead generation

- Spearheaded a consulting firm providing innovation, technology transfer, and entrepreneurship services for governments, academic institutions, VCs and startups- Asset analysis in therapeutic platforms, medical devices, and broad range of technology modalities

Member of RTP Angel Fund

Provided expert mentoring and training as part of the Leaders in Innovation Fellowship (LIF 1, 2, 3, 4 & 7) programs, awarded to Oxentia by the Royal Academy of Engineering (Newton Fund UK)

- Led global business development at Tekcapital Plc., an investment group creating market value from university intellectual property assets- Identified key business leads and created alliances with new clients

- Formed partnerships with commercial and R&D partners, and academic institutions in Latin America for Oxentia Ltd., a global strategy and innovation group - Managed market/consulting contracting strategy and negotiations to bring in new business contracts

- Conducted due-diligence, market and IP analysis, and created succinct documents about the value of emerging life science technologies- Licensing negotiations with large corporations and startups- Managed key alliances between Oxford University, the Royal Academy of Engineering, and Cambridge University- Developed new business and fostered key relationships from private industry, universities, research centers and government agencies in the UK and worldwide- Coordinated and led a BD team (7 members)- Delivered science and technology focused training services to researchers and ecosystem stakeholders in th U.K. and globally

- Performed cutting-edge nano-biotechnology and oligonucleotide therapeutics research - 6 publications in top-ranked journals- EPSRC Developing Future Leaders-Women in Science Grant- Coordinated collaborative work with researchers at the University of Warwick, Southampton University, and University of York- Supervised research and mentored undergraduate and graduate students, as well as research projects for the Life Sciences Interface Doctoral Training Centre

- Synthesized anti-cancer drugs and studied studies their anti-tumorigenic effects and interactions with DNA structures - Research leading to 8 publications in leading Chemistry and Biochemistry journals

Adviser: Dr. Bhimu Patil - Isolated and studied natural products extracted from citrus seeds